Arun J. Sanyal, Veronica Miller  Gastroenterology 

Slides:



Advertisements
Similar presentations
Bin Gao, Hidekazu Tsukamoto  Gastroenterology 
Advertisements

Covering the Cover Gastroenterology
Abhishek Chauhan, David H. Adams  Gastroenterology 
Unraveling the Role of PD-1/PD-L Interactions in Persistent Hepatotropic Infections: Potential for Therapeutic Application?  Henry Radziewicz, Holly L.
Volume 153, Issue 3, Pages e7 (September 2017)
Another Earth: Innate Lymphoid Cells and Intestinal Inflammation
Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Huiqin He, Zhinong Jiang, Leimin Sun  Gastroenterology 
Volume 152, Issue 4, Pages (March 2017)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Volume 153, Issue 3, Pages e7 (September 2017)
Covering the Cover Gastroenterology
Volume 151, Issue 2, Pages (August 2016)
Volume 152, Issue 5, Pages (April 2017)
Volume 145, Issue 4, Pages (October 2013)
Outcomes Among Living Liver Donors
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
David L. McCollum, J. Martin Rodriguez 
Defensins Versus Bacteria: Not Just Antibiotics Anymore
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Gastroenterology 2011–2016: Looking Back and Forward
Electronic Clinical Challenges and Images in GI
From Embryonic Stem Cells to β-Cells: New Hope for Diabetics?
Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Targeting the FXR Nuclear Receptor to Treat Liver Disease
Volume 134, Issue 5, Pages (May 2008)
Clinical Challenges and Images in GI
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
The Bone Marrow and Liver Fibrosis: Friend or Foe?
Jean-Michel Pawlotsky  Gastroenterology 
Challenges to the Therapeutic Pipeline for Irritable Bowel Syndrome: End Points and Regulatory Hurdles  Michael Camilleri, Lin Chang  Gastroenterology 
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis
Efficient Early Drug Development for Ulcerative Colitis
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
HCV, Iron, and Oxidative Stress: The New Choreography of Hepcidin
Volume 133, Issue 2, Pages (August 2007)
Volume 150, Issue 7, Pages (June 2016)
Volume 155, Issue 2, Pages (August 2018)
AGA technical review on nonalcoholic fatty liver disease
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Pavel Strnad, M. Bishr Omary  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
Volume 141, Issue 1, Pages (July 2011)
Colorectal Cancer Screening: How to Stop a Moving Target
Volume 150, Issue 7, Pages (June 2016)
The Dawning of a New Editorial Board for Gastroenterology
Volume 149, Issue 6, Pages (November 2015)
Volume 142, Issue 4, Pages e6 (April 2012)
Volume 151, Issue 4, Pages (October 2016)
Richard Blumberg, Judy Cho, James Lewis, Gary Wu  Gastroenterology 
Volume 140, Issue 7, Pages (June 2011)
Jonathan T. Hlivko, Mitchell L. Shiffman, R. Todd Stravitz, Velimir A
Volume 139, Issue 1, Pages (July 2010)
Changing of the Guards: 2011–2016 Gastroenterology Team
Would Free Fatty Acids Enhance Treatment of Obesity?
Inflammatory pathways in alcoholic steatohepatitis
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 138, Issue 6, Pages (May 2010)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Electronic Clinical Challenges and Images in GI
Controversies in Liver Transplantation for Hepatitis C
Craig Lammert, Megan Comerford, Joshua Love  Gastroenterology 
Volume 142, Issue 7, Pages (June 2012)
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
Volume 146, Issue 4, Pages (April 2014)
Presentation transcript:

Regulatory Science and Drug Approval for Alcoholic and Nonalcoholic Steatohepatitis  Arun J. Sanyal, Veronica Miller  Gastroenterology  Volume 150, Issue 8, Pages 1723-1727 (June 2016) DOI: 10.1053/j.gastro.2016.02.044 Copyright © 2016 AGA Institute Terms and Conditions

Figure 1 Pathophysiological drivers of alcoholic hepatitis are shown. Several of these are potentially targetable for therapeutics. Alcohol impairs the integrity of the intestinal barrier leading to enhanced endotoxemia and systemic exposure to bacterial products, which activate the innate immune system and sensitize hepatic macrophages. Frequently, after a bout of binge drinking, there is increased endotoxemia and activation of severe hepatic inflammation and cholestasis along with liver injury and cell death. The intestinal barrier function (1), cytokines (2), bile acid-related cholestatic and immune-inflammatory pathways (3), genetics and inflammasome (4), and cell death−modifying pathways (5) have been or are under active clinical investigation. LPS, lipopolysaccharide. Gastroenterology 2016 150, 1723-1727DOI: (10.1053/j.gastro.2016.02.044) Copyright © 2016 AGA Institute Terms and Conditions

Arun J. Sanyal Gastroenterology 2016 150, 1723-1727DOI: (10.1053/j.gastro.2016.02.044) Copyright © 2016 AGA Institute Terms and Conditions

Veronica Miller Gastroenterology 2016 150, 1723-1727DOI: (10.1053/j.gastro.2016.02.044) Copyright © 2016 AGA Institute Terms and Conditions